Antibiotic resistance patterns and extended-spectrum β-lactamase production among Acinetobacter spp. isolated from an intensive care Unit of a hospital in Kerman, Iran

Antimicrobial Resistance and Infection Control

Volumn 1, Issue , 2012, Pages

  Shakibaie, Mohammad R ^a   Adeli, Saied ^a   Salehi, Mohammad H ^a  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acinetobacter spp; antibiotic resistance; extended spectrum lactamase; MIC

Indexed keywords

AMIKACIN; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; TETRACYCLINE;

ACINETOBACTER; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; DISK DIFFUSION; ENZYME SYNTHESIS; HUMAN; HYDROLYSIS; IRAN; NONHUMAN; PRIORITY JOURNAL; UNIVERSITY HOSPITAL;

EID: 84897129048     PISSN: None     EISSN: 20472994     Source Type: Journal    
DOI: 10.1186/2047-2994-1-1     Document Type: Article

References (27)

1. Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 1996, 9:148-165. 172888, 8964033.
2. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008, 21:538-582. 10.1128/CMR.00058-07, 2493088, 18625687.
3. Looveren MV, Goossens H, Van MH. Antimicrobial resistance of Acinetobacter spp. in Europe. Clin Microbiol Infect 2004, 10:684-704. 10.1111/j.1469-0691.2004.00942.x, 15301671.
4. Borcan E, Ghiţǎ CM, Chifiriuc MC, Mǎruţescu L, Isar C, Lazǎr V. Antibiotic resistance of Gram negative bacilli strains isolated from the Intensive Care Unit in Fundeni Clinical Institute, Bucharest, Romania. Roum Arch Microbiol Immunol 2009, 68:228-234.
5. Joseph M, Sistla S, Dutta TK, Badhe AS, Rasitha D, Parija S. Ventilator-associated pneumonia in a tertiary care hospital in India: role of multi-drug resistant pathogens. J Infect Dev Ctries 2010, 4:218-225.
6. Blot S, Vandewoude K, Colardyn F. Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study. Intensive Care Med 2003, 29:471-475.
7. Kim C, Lee Y, Lee H, Woo J, Song W, Kim M, Leeh W, Jung SH, Lee K, Chong Y. Prevalence and diversity of carbapenemases among imipenem-nonsusceptible Acinetobacter isolates in Korea: emergence of a novel OXA-182. Diagn Microbiol Infect Dis 2010, 68:432-438. 10.1016/j.diagmicrobio.2010.07.014, 20884158.
8. Takahashi A, Yomod AS, Kobayashi I, Okubo T, Tsunoda M, Iyobe S. Detection of carbapenemase-producing Acinetobacter baumannii in a hospital. Antimicrob Agents Chemother 2000, 38:526-529.
9. Sinha M, Srinivasa H, Macaden R. Antibiotic resistance profile & extended spectrum beta-lactamase (ESBL) production in Acinetobacter species. Indian J Med Res 2007, 126:63-67.
10. Guillou J, Vallee E, Bergogne-Berezin E, Phillipon A. Distribution of β-lactamase and phenotype analysis in clinical strains of Acinetobacter calcoaceticus. J Antimicrob Agents Chemother 1988, 45:22597-22604.
11. Perilli M, Felici A, Oratore A, Cornaglia G, Bonfiglio G, Rossolini GM, Amicosante G. Characterization of the chromosomal cephalosporinases produced by Acinetobacter lwoffii and Acinetobacter baumannii clinical isolates. Antimicrob Agents Chemother 1996, 40:715-719. 163186, 8851599.
12. Henwood C, Gatward T, Warner M, James D, Stockdele W, Spence R, Towner KJ, Livermore MD, Woodford N. Antibiotic resistance among clinical isolates of Acinetobacter in the UK and in vitro evaluation of tigacycline (GAR-936). J Antimicrob Chemother 2002, 49:479-487. 10.1093/jac/49.3.479, 11864948.
13. Khosroshahi N, Sharifi M. Isolation of A. baumannii resistant to carbapenems from ICU patients. Iran J Med Microbiol 2009, 1(3):33-38.
14. Farahani R, Moniri R, Shajari G, Nazem Shirazi MH, Musavi G, Ghasemi A, Haj Aghazadeh S. Antibiotic resistance of Acinetobacter sp. isolated from Shahid Beheshti Hospital, Kashan. Faiz 2009, 4:60-66., http://feyz.kaums.ac.ir
15. Junie E. Interspecies transformation of Acinetobacter: genetic evidence for a ubiquitous genus. J Bacteriol 1972, 1112:917-931.
16. Bouvet PJ, Grimont PA. Identification and biotyping of clinical isolates of Acinetobacter. Ann Inst Pasteur Microbiol 1987, 138:569-578. 10.1016/0769-2609(87)90042-1, 3440090.
17. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing: 17th informational supplement. Wayne, PA: CLSI 2007, M100-S17. Clinical and Laboratory Standards Institute.
18. Paterson DL, Bonomo RA. Extended-spectrum B-lactamases: a clinical update. Clinical Microbiol Rev 2005, 1:657-686.
19. Tzelepi E, Giakkoupi A, Sofianou D, Loukova V, Kemeroglou A, Tsakris A. Detection of extended-spectrum beta-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes. J Clin Microbiol 2000, 38:542-546. 86144, 10655342.
20. Jiang XF, Han LZ, Yuan FY, Jiang YF, Liu Y, Ni Y, Lu Y, Hong XH. Double inhibitor parallel inhibit disk test to effectively analyze ESBLs in Enterobacteriaceae isolates. Chin J Lab Med 2005, 28:1018-1021.
21. Cefai C, Richards J, Gould FK, McPeake P. An outbreak of Acinetobacter respiratory tract infection resulting from incomplete disinfection of ventilatory equipment. J Hosp Infect 1990, 15:177-182. 10.1016/0195-6701(90)90128-B, 1969441.
22. Perez F, Hujer AM, Hujer KM, Decker B, Rather P, Bonomo R. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2007, 51:3471-3484. 10.1128/AAC.01464-06, 2043292, 17646423.
23. Jacoby GA, Han P. Detection of extended-spectrum beta lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol 1996, 34:908-911. 228915, 8815106.
24. Feizabadi M, Fatollahzadeh B, Rasoolinejad M, Aligholi M, Soroush S, Mohammadi S. Antimicrobial susceptibility patterns and distribution of blaOXA genes among Acinetobacter spp. isolated from patients in Tehran hospitals. Jpn J Infect Dis 2008, 61:274-278.
25. Coyne S, Courvalin P, Périchon B. Efflux-mediated antibiotic resistance in Acinetobacter spp. Antimicrob Agents Chemother 2011, 55:947-953. 10.1128/AAC.01388-10, 3067115, 21173183.
26. Lagatolla C, Tonin EA, Monti-Bragadin C, Dolzani L, Gombac F, Bearzi C, Edalucci E, Gionechetti F, Rossolini GM. Endemic carbapenem-resistant Pseudomonas aeruginosa with acquired metallo-β-lactamase determinants in European hospital. Emerg Infect Dis 2004, 10:535-538.
27. Pirel L, Menuteau O, Agoli N, Cattoen C, Nordmann P. Outbreak of extended-spectrum beta-lactamases VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. J Clin Microbiol 2003, 41:3542-3547. 10.1128/JCM.41.8.3542-3547.2003, 179787, 12904353.